Responding to PANS Skepticism

It takes roughly 17 years for research to trickle into clinical practice, so an educational gap exists for many clinicians who haven’t yet been apprised of advances in the field.

Be kind and collaborative rather than argumentative.

Acknowledge that there is a substantial need for more research to better understand PANS. Give to support research if you’re able to.

Share peer reviewed research, clinical trials, and PANS/PANDAS publications.

Point out a decade plus of endorsements and publications from medical institutions including Stanford, Columbia, Harvard, Dartmouth, and NIMH.

Link to the diagnostic criteria detailed in the 2013 JCAP PANS Consensus Guidelines and treatment considerations in the the 2017 PANS Treatment Guidelines.

Link to the peer-reviewed Special Issue based on Neuroimmune’s Inflammatory Brain Disorders Conference published in Developmental Neuroscience detailing advances in PANS/PANDAS.

Invite clinicians to attend Neuroimmune’s Inflammatory Brain Disorders Conference where they can not only earn CME credits but learn the latest research and ask questions of experts in the field.

Encourage clinicians to participate in Neuroimmune’s accredited Continuing Medical Education (CME) on PANS/PANDAS led by experts from Stanford, Harvard, NIMH, Yale, and other reputable institutions.

Invite clinicians to submit challenging and complex cases to our Expert Consultation Panel where they can dialogue with physicians from Stanford, UCSF, Harvard, NIMH, and Albert Einstein Medical School.

Advocate for shared decision making. Engage clinicians who strongly agree patients and families deserve a say in healthcare decisions that impact them.

Promote understanding of treatment options by linking to our PANS Treatment and Diagnosis Guides, compiled in collaboration with Stanford.

Share our free Clinician Resources which serve as a guide for individuals wanting to learn more about PANS/PANDAS.